- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Terelizumab (aka Tislelizumab)
Total 2684 results
-
BeiGeneMyriad Genetic Laboratories, Inc.CompletedSolid TumorsUnited States, Spain, United Kingdom, France, Australia, New Zealand
-
Fujian Cancer HospitalRecruitingCarcinoma | Cervix CarcinomaChina
-
Peking Union Medical College HospitalRecruitingHepatocellular CarcinomaChina
-
Beijing Friendship HospitalRecruitingLocally Advanced Rectal CancerChina
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
Johns Hopkins UniversityGenentech, Inc.Active, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom, Australia, Belgium, Brazil, Croatia, France, Canada, Slovakia, Germany, Netherlands, Norway, Italy, Poland, Switzerland, Romania, Bulgaria, Spain, Mexico, Austria, Portugal, Turkey, Sweden, Argentina, Denmark and more
-
University of California, San FranciscoGenentech, Inc.Completed
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Guangdong Provincial People's HospitalRecruitingHepatocellular CarcinomaChina
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Dr Recai TurkogluHealth Sciences University Istanbul Haydarpaşa Numune Training and Research...Active, not recruiting
-
Fujian Medical University Union HospitalRecruitingUrinary Bladder Neoplasms | Treatment Outcome | Neoplasm Recurrence, Local | Multicenter Study | Immunotherapy, Active | BCG VaccineChina
-
Lai-ping ZhongSun Yat-sen University; Fudan University; Fujian Medical University; Central South...RecruitingOral Squamous Cell Carcinoma | Locally Advanced Head and Neck CarcinomaChina
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
Chinese PLA General HospitalRecruitingAdvanced Gastroesophageal Adenocarcinoma | First-line Therapy | PDL1 CPS < 5China
-
Fujian Cancer HospitalNot yet recruiting
-
Wuhan Union Hospital, ChinaNot yet recruitingCarcinoma | Intrahepatic Cholangiocarcinoma | Gallbladder Cancer | Immunotherapy | Tislelizumab | Surufatinib | Angiogenesis Inhibitors | Antineoplastic Agents, Immunological
-
UNICANCERRecruitingTesting Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions (HESTIA)Hepatocellular Carcinoma by BCLC StageFrance
-
Barretos Cancer HospitalCompleted
-
BeiGeneNot yet recruiting
-
BeiGeneActive, not recruiting
-
BeiGeneCompleted
-
Zhejiang Cancer HospitalActive, not recruiting
-
BeiGeneRecruitingMelanoma | Renal Cell Carcinoma | Urothelial CarcinomaChina
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
Hoffmann-La RocheCompletedUlcerative ColitisUnited States, Australia, Serbia, Hong Kong, Brazil, Bulgaria, Estonia, Poland, Russian Federation, Mexico, Ukraine, Argentina, France, Slovakia
-
Brigham and Women's HospitalGenentech, Inc.; Boston Medical CenterNot yet recruiting
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisCanada, United Kingdom, Belgium, Brazil, Croatia, Mexico, Slovakia, Ireland, Netherlands, Estonia, Norway, Denmark, Italy, Poland, Spain, Bulgaria, France, Turkey, Portugal, Sweden, Argentina, Kuwait, Slovenia, Czechia, Hungary, Finland
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
Immune-Onc TherapeuticsCompletedAdvanced Solid TumorChina
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis, Relapsing-RemittingNetherlands
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AG; Institut du Cerveau et de la Moelle épinièreRecruitingMultiple Sclerosis | Relapse | Primary Progressive Multiple SclerosisFrance
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Spain, Austria, Czechia, Italy, Hungary, Australia, Portugal, Serbia, Canada, Germany, United Kingdom, Poland, Romania, Croatia, Israel, Belgium, Bulgaria, Estonia, Switzerland, Mexico, Lithuania, New Zealand, France, Slo... and more
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
Hoffmann-La RochePPD; Laboratory Corporation of America; Illingworth Research GroupActive, not recruitingMultiple Sclerosis | Clinically Isolated SyndromeUnited States, Spain, United Kingdom, Germany
-
Johns Hopkins UniversityGenentech, Inc.Completed
-
Yale UniversityGenentech, Inc.TerminatedMultiple Sclerosis | Radiologically Isolated SyndromeUnited States
-
NYU Langone HealthGenentech, Inc.CompletedMultiple SclerosisUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, United Kingdom, Australia, Netherlands, Ireland, Norway, Turkey, Estonia, Denmark, Germany, Italy, Spain, Switzerland, France, Finland, Sweden, Czechia
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Selayang HospitalCompletedAcute Kidney Injury | Acute Renal Failure | Kidney Failure, Acute | Hospital Acquired ConditionMalaysia
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
BeiGeneActive, not recruiting
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Completed
-
BeiGeneNot yet recruitingMetastatic Solid Tumor | Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Alpha-fetoprotein (AFP)-Producing Gastric Cancer | Extragonadal Yolk Sac Tumors | Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer